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Objective: Vascular surgery patients have high readmission rates, and identiﬁcation of high-risk groups that may be
amenable to targeted interventions is an important strategy for readmission prevention. This study aimed to determine
predictors of unplanned readmission and develop a risk score for predicting readmissions after vascular surgery.
Methods: The National Surgical Quality Improvement Program database for 2011 was queried for major vascular surgical
procedures. The primary end point was unplanned 30-day readmissions. The data were randomly split into two-thirds for
development and one-third for validation. Multivariable logistic regression was used to create and validate a point score
system to predict unplanned readmissions.
Results: Overall, 24,929 patients were included, with 2507 readmissions (10.1%). A point-based scoring system was
developed with the use of factors predictive for readmission, including procedure type; discharge destination; race; non-
elective presentation; pulmonary, renal, and cardiac comorbidities; diabetes; steroid use; hypoalbuminemia; anemia;
venothromboembolism before discharge; graft failure before discharge; and bleeding disorder. The point score stratiﬁed
patients into 3 groups: low risk (0-3 points) with a readmission rate of 5.4%, moderate risk (4-7 points) with a read-
mission rate of 8.6%, and high risk ($8 points) with a readmission rate of 16.4%. The model had a C-statistic [ 0.67.
Conclusions: Through the use of patient, operative, and predischarge events, this novel vascular surgery-speciﬁc read-
mission score accurately identiﬁed patients at high risk for 30-day unplanned readmission. This model could help direct
discharge and home health care resources to patients at high risk, ultimately reducing readmissions and improving
efﬁciency. (J Vasc Surg 2014;59:1340-7.)Readmissions represent a major burden to both
patients and the health care system at large.1 The ﬁnancial
impact is signiﬁcant, with an estimated 17.4 billion dollars
in Medicare spending on unplanned readmissions in 2004
alone.2 Although many readmissions may be necessary,
others may be avoidable and perhaps predictable. Under-
standing driving factors and high-risk circumstances may
help direct future resources and interventions. The impor-
tance of identifying high-risk procedures and understand-
ing the clinical circumstances surrounding unplanned
readmissions is made ever more pressing by Centers for
Medicare and Medicaid Services (CMS) changes focused
on decreasing readmission rates with policies aimed at
requiring rehospitalization reporting.3 CMS currently fo-
cuses on medical readmissions but probably will expand
to surgical cases in 2015.4 Vascular surgery has been ear-
marked as an important area for readmission reduction.5,6
Value-based purchasing readmission policy may eventually
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0reducing reimbursement.4 Future initiatives on reducing
surgical readmissions probably will focus on unplanned
readmissions related to the index procedure.
Readmission research is in a ﬂedgling state, and a call
has been made to identify and predict readmission among
vascular surgery patients.4 This study is aimed at identifying
risk factors for rehospitalization after the most commonly
performed vascular procedures and create a risk score to
identify high-risk patients who may require increased
resource utilization. A risk score will in turn help create
strategies aimed at preventing readmission in high-risk
vascular surgery patients.
METHODS
This was a retrospective review of prospectively collected
data from the National Surgical Quality Improvement
Program (NSQIP) participant user ﬁle for 2011. The
NSQIP sampling strategy, parameters, and outcomes that
are collected have been previously reported.7 NSQIP
collects patient demographics, preoperative comorbid
conditions, preoperative laboratory values, Current Proce-
dural Terminology codes (CPT), postoperative Interna-
tional Classiﬁcation of Diseases, 9th edition (ICD-9)
codes, operative characteristics, length of stay, and
postoperative outcomes at 30 days through chart review,
collection of records, and patient telephone interviews.
The 2011 NSQIP database included data on unplanned
readmissions for the ﬁrst time with categorization by
planned and unplanned readmissions. This analysis will focus
on unplanned readmissions, deﬁned by NSQIP as readmis-
sion to any hospital within 30 days and related to the index
procedure.
The 2011 NSQIP database was queried for patients
undergoing major vascular surgery procedures identiﬁed
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dures were identiﬁed by CPT code as described previously
and by determining those procedures most frequently per-
formed by vascular surgeon subspecialists.8 Procedures
were grouped on the basis of anatomical considerations
such as carotid endarterectomy (CE), open abdominal
aortic aneurysms (AAAs), endovascular abdominal aortic
repair (EVAR), lower extremity bypass with either vein or
graft, lower extremity amputation, or other major vascular
procedures including arterial and venous bypass (ie, extra-
anatomical bypass, mesenteric vessel bypass). Included
CPT codes by grouping classiﬁcation are listed in the
Appendix (online only). Open and endovascular thoracic
aortic repairs were excluded because of insufﬁcient sample
size. Patients were excluded who died before discharge or
whose postoperative length of stay exceeded 30days because
they would not contribute to those at risk for readmission.
Variable deﬁnitions. NSQIP includes the demo-
graphics age, sex, and race. Race was analyzed as white,
black, or other. Preoperative comorbidities were analyzed
by organ system as previously described and include pul-
monary comorbidities (chronic obstructive pulmonary
disease, pneumonia, ventilator dependency), cardiac com-
orbidities (congestive heart failure, prior myocardial infarc-
tion, prior percutaneous coronary intervention, prior
cardiac surgery, and angina within 1 month of surgery),
neurological comorbidities (impaired sensorium, coma
>24 hours, hemiplegia, paraplegia, quadriplegia, history
of transient ischemic attack, prior stroke with or without
neurological deﬁcit, or tumor involving the central nervous
system), renal comorbidity (preoperative dialysis or acute
renal failure), and hepatic comorbidity (ascites or esopha-
geal varices). Speciﬁc component NSQIP deﬁnitions are
available on the ACS-NSQIP website (http://site.
acsnsqip.org).9-11 Additional preoperative risk factors
included diabetes, smoking within the past year, alcohol
dependency (>2 alcoholic beverages daily) bleeding dis-
order, steroid use for chronic condition, >10% weight loss
within 6 months, body mass index (BMI) analyzed cate-
gorically as underweight (BMI, <19), normal (19-25),
overweight (BMI, 25-29), and obese (BMI, >29).
Chemotherapy within 30 days, disseminated cancer, and
radiation within 90 days were grouped together. Func-
tional status was analyzed as full ability to perform activities
of daily living compared with partial or complete de-
pendency in the 30 days before surgery. Admission status
was analyzed as home or transfer from another facility.
Patient discharge location was analyzed as home compared
with nursing facility that was the patient’s original location
compared with a new rehabilitation or other nursing
facility.
Other preoperative risk factors included American
Society of Anesthesiologists (ASA) classes 1 or 2 compared
with 3, 4, or 5; wound class grouped as class I and II
(clean, clean contaminated) compared with III and IV
(contaminated, dirty/infected). Preoperative sepsis and
systemic inﬂammatory response syndrome were also group-
ed together. Preoperative hypoalbuminemia was deﬁned asserum albumin <3.5 g/dL, and anemia was deﬁned as
hematocrit <36. Missing data were input as the reference
group for binary variables because this is a conservative
approach, biasing parameter estimates toward the null.
Postoperative complications within 30 days were
grouped according to organ system as previously described
including incisional infection, urinary tract infection, car-
diac events, neurological event, prolonged ventilation or
reintubation, pneumonia, return to operative room, renal
failure, and sepsis.12,13 Venothromboembolism (VTE;
either pulmonary embolism or deep-vein thrombosis diag-
nosed by relevant radiological studies) and graft failure
within 30 days were also analyzed. Only complications
that occurred before discharge were analyzed.
Statistical analysis. The primary end point was un-
planned readmission within 30 days after the index opera-
tion. The data set was split, with two-thirds allocated for
model development (n ¼ 16,660) and one-third for model
validation (n ¼ 8329).10 Clinical characteristics associated
with readmissions were initially assessed by means of c2,
Student t-test, Mann-WhitneyU test, or Fisher exact test as
appropriate to the data. Factors meeting criteria of P < .1
were considered for entry into the predictive model for
readmission. A manual stepwise binary logistic regression
was performed. Successive models were evaluated by use of
change in deviance, in which only variables that had a
statistically signiﬁcant improvement in model performance
were included. Model performance was then assessed by
means of the C-statistic of a receiver operator curve and
Hosmer-Lemeshow goodness-of-ﬁt test (a measure of
model ﬁt).
The point scoring system was developed from the
b coefﬁcients derived from the developmental multivariable
binary logistic regression. The total readmission risk score
includes the sum of points for each present risk factor.
The predictive ability of the model was tested against the
validation dataset and assessed by means of the C-statistic
of a receiver operator curve. All analyses were carried out
at the University of Rochester with the use of IBM SPSS
statistical software version 20.0 (2012 SPSS, Inc, Armonk,
NY). This study did not contain any protected health infor-
mation because of the deidentiﬁed nature of the data,
which is not considered human research and therefore
not subject to institutional review board approval.RESULTS
A total 24,929 cases met inclusion criteria. This cohort
included CE in 8843 cases (35.5%), representing the most
frequent procedure, peripheral arterial intervention in 3933
(15.8%) cases, AAA in 1556 cases (6.2%), EVAR in 3490
(14.0%) cases, lower extremity amputation in 2809
(11.3%) cases, and other major vascular procedures in
4298 (17.2%) cases. The overall readmission rate was
10.1% (n ¼ 2507). Unplanned readmission was most com-
mon in peripheral procedures at 15.2% (n ¼ 608) and
lower extremity amputation at 15.0% (n ¼ 443), and least
common after CE at 6.2% (n ¼ 551) (Table I).
Table I. Readmission rates by procedure type
Procedure
Total
(N ¼ 24,929),
No. (%)
Overall
readmission
(n ¼ 2765),
No. (%)
(11.1%)
Unplanned
readmissions
(n ¼ 2507),
No. (%)
(10.1%)
Open AAA
repair
1556 (6.2) 159 (10.2) 149 (9.2)
EVAR 3490 (14.0) 281 (8.1) 261 (7.5)
Peripheral 3933 (15.8) 654 (16.6) 608 (15.2)
Carotid 8843 (35.5) 673 (7.6) 551 (6.2)
Amputation 2809 (11.3) 471 (15.9) 443 (15.0)
Other 4298 (17.2) 530 (12.3) 500 (11.3)
AAA, Abdominal aortic aneurysm; EVAR, endovascular abdominal aortic
repair.
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ical variables are listed in Table II. Mean population age
was 69.6 6 11.0 years, the majority of patients were white
(86.5%), male (64.7%), discharged home (79.6%) and were
ASA class III, IV, or V (94.0%). Other factors associated
with unplanned readmission on bivariate analysis include
smoking; diabetes mellitus; chronic steroid use; dependent
functional status; peripheral vascular disease; rest pain,
gangrene, or prior amputation; pulmonary, cardiac, renal,
and neurologic comorbidities; bleeding disorder; chemo-
therapy or radiotherapy; weight loss >10% in past
6 months; preoperative sepsis or systemic inﬂammatory
response syndrome; preoperative transfusion; preoperative
anemia; hypoalbuminemia; wound class; urgent or emer-
gent surgery; graft failure before discharge; VTE before
discharge; and discharge destination. Age, BMI, hepatic
insufﬁciency, and alcohol use were not associated with
readmission (Table II).
On multivariable binary logistic regression with the use
of the development dataset, the following factors were
independent predictors of 30-day unplanned readmission:
black race (odds ratio [OR], 1.21; 95% conﬁdence interval
[CI], 1.04-1.41; P ¼ .014); bleeding disorder (OR, 1.19;
95% CI, 1.05-1.36; P ¼ .008); diabetes mellitus (OR,
1.13; 95% CI, 1.00-1.28; P ¼ .044); renal comorbidity
(OR, 1.24; 95% CI, 1.02-1.50; P ¼ .033); cardiac comor-
bidity (OR, 1.28; 95% CI, 1.13-1.44; P < .001); chronic
steroid use (OR, 1.36; 95% CI, 1.07-1.73; P ¼ .012);
hypoalbuminemia (OR, 1.35; 95% CI, 1.18-1.55; P <
.001); anemia (OR, 1.26; 95% CI, 1.10-1.43; P ¼ .001);
nonelective case (OR, 1.15; 95% CI, 1.02-1.31; P ¼
.027); operative time >150 minutes (OR, 1.17; 95% CI,
1.01-1.34; P ¼ .031); procedure type (reference group:
CE), open AAA (OR, 1.53; 95% CI, 1.18-1.98), lower-
extremity bypass (OR, 1.93; 95% CI, 1.59-2.34; P <
.001), amputation (OR, 1.24; 95% CI, 0.99-1.53; P ¼
.057), EVAR (OR, 1.06; 95% CI, 0.85-1.32; P ¼ .031)
and other major procedure (OR, 1.49; 95% CI, 1.24-
1.80; P < .001); discharge destination (reference group:
home): rehab or other facility (OR, 1.30; 95% CI, 1.12-
1.50; P < .001), skilled nursing facility (OR, 1.54; 95%
CI, 1.13-2.10; P ¼ .007); graft failure before discharge
(OR, 2.07; 95% CI, 1.03-4.13; P ¼ .04); and VTE before
discharge (OR, 1.83; 95% CI, 1.00-3.36; P ¼ .050)
(Table III). The regression model had modest predictive
ability (C-statistic ¼ 0.67) with appropriate model ﬁt
(Hosmer-Lemeshow goodness of ﬁt ¼ 0.09). This model
also showed good predictive ability in the validation dataset
(C-statistic ¼ 0.64) and precise model ﬁt (Hosmer-Leme-
show goodness of ﬁt ¼ 0.66).
The model from the developmental dataset was used to
generate a point-scoring system for each signiﬁcant predic-
tive factor (Table IV). Point values ranged from 0-5. To
calculate a risk score for unplanned readmission, points
are tallied for each risk factor including discharge destina-
tion (home ¼ 0 points, new nursing facility ¼ 2 points,
prior residence at nursing facility ¼ 3 points), pulmonary
comorbidity (2 points), cardiac comorbidity (2 points),renal insufﬁciency (1 point), diabetes mellitus (1 point),
steroids for chronic condition (2 points), bleeding disorder
(1 point), black race (1 point), operative time>150minutes
(1 point), hypoalbuminemia (2 points), anemia (2 points),
nonelective case (1 point), VTE before discharge (4 points),
graft failure before discharge (5 points), and procedure type
(CE ¼ 0 points, EVAR ¼ 0 points, amputation ¼ 1 point,
AAA ¼ 3 points, miscellaneous procedure ¼ 3 points, and
peripheral intervention ¼ 5 points). The minimum point
score was 0; the maximum was 26. The mean value was
6.2 points (standard deviation ¼ 4.8).
The predicted probability of readmission by risk score
is presented in Fig 1. The predicted probability of readmis-
sion compared with the actual readmission rate in the vali-
dation dataset is presented in Fig 2. The point score was
then stratiﬁed into thirds by percentile, low risk (0-3
points) had a predicted readmission rate of 5.4%
(observed ¼ 5.5%), moderate risk (4-7 points) a predicted
readmission rate of 8.6% (observed ¼ 8.4%), and high risk
($8 points) had a predicted readmission rate of 16.4%
(observed ¼ 14.6%). Compared with patients in the low-
risk group, moderate-risk patients had a 70% increased
risk of readmission (OR, 1.7; 95% CI, 1.50-1.93; P <
.001), whereas the high-risk group was 3.4 times as likely
to be readmitted within 30 days (OR, 3.44; 95% CI,
3.08-3.83; P < .001). The highest-risk patients (top 5
percentile) had a readmission risk score of $14 and a pre-
dicted readmission rate of 35.2%.
DISCUSSION
This study is the ﬁrst to use a large, clinically validated
database in NSQIP to identify risk factors for readmission
as well as create a risk score to predict unplanned readmis-
sions in vascular patients. This risk score incorporates pre-
operative comorbidities, laboratory studies, postoperative
events, and discharge location. Furthermore, it includes
relative rates of readmission between vascular procedures,
allowing a single score for most patients seen on a vascular
surgery service.
Given the growing focus on readmissions and the
increasing pressure to prevent unplanned readmissions,
Table II. Clinical characteristics of the patient populationa
Total population No readmission Readmission P value
Total group 25,369 22,862 (89.9) 2507 (10.1) -
Sex <.001
Male 16,379 (64.7) 14,818 (64.8) 1561 (62.3)
Female 8944 (35.3) 7940 (34.7) 1004 (37.7)
Ages, years 69.6 6 11.0 69.7 6 10.9 69.5 6 11.5 .483
Race <.001
White 20,128 (86.5) 18,196 (79.6) 1932 (80.8)
Black 2584 (11.1) 2177 (9.5) 407 (17.0)
Other 559 (2.4) 507 (2.2) 53 (2.2)
BMI $30 7358 (29.5) 6578 (28.8) 780 (10.6) .114
Diabetes mellitus 8004 (31.6) 6969 (30.4) 1035 (41.3) <.001
Smoker 8912 (35.1) 7942 (34.7) 970 (38.7) .003
Alcohol use 534 (2.1) 484 (2.1) 50 (2.0) .561
Dependent functional status 2581 (10.2) 2146 (9.4) 435 (17.4) <.001
Pulmonary comorbidity 3812 (15.0) 3318 (14.5) 494 (19.7) <.001
Hepatic insufﬁciency 38 (0.1) 31 (0.1) 7 (0.3) .101b
Cardiac comorbidity 6192 (24.4) 5370 (23.5) 822 (32.8) <.001
Renal insufﬁciency 1235 (4.9) 992 (4.3) 243 (9.7) <.001
Neurologic comorbidity 3425 (13.5) 3039 (13.3) 386 (15.4) .016
Steroids for chronic condition 911 (3.6) 771 (3.4) 140 (5.6) <.001
Bleeding disorders 5135 (20.2) 4478 (19.6) 657 (26.2) <.001
Chemo/XRT 164 (0.6) 137 (0.6) 27 (1.1) .007
Weight loss 317 (1.2) 269 (1.2) 48 (1.9) .003
Preoperative sepsis/SIRS 1464 (5.8) 1214 (5.3) 250 (10.0) <.001
Preoperative transfusion 735 (2.9) 612 (2.7) 123 (4.9) <.001
HCT #36a 8743 (35.3) 7519 (3.3) 1224 (48.8) <.001
Hypoalbuminemia (<3.5 g/dL) 4659 (34.1) 3901 (17.1) 758 (30.2) <.001
ASA III, IV, and V 23,812 (94.0) 21,340 (93.3) 2472 (98.6) <.001
Wound class III, IV 1029 (4.1) 880 (3.8) 149 (5.9) <.001
Peripheral vascular disease 3454 (13.6) 2936 (12.8) 518 (20.7) <.001
Rest pain/gangrene/prior amputation 2368 (9.3) 1957 (8.6) 411 (16.4) <.001
Nonelective surgery 7323 (28.9) 6316 (27.6) 1007 (40.2) <.001
Discharge destination <.001
Home 19,897 (78.4) 18,199 (79.6) 1671 (67.7)
Facility that is home 476 (1.9) 390 (1.7) 86 (3.4)
New facility 4626 (18.5) 3882 (17.0) 744 (29.7)
Graft failure before discharge 67 (0.3) 50 (0.2) 17 (0.7) <.001
Venothromboembolism before discharge 114 (0.4) 91 (0.4) 23 (0.8) <.001
ASA, American Society of Anesthesiology; BMI, body mass index; Chemo/XRT, chemotherapy and x-ray therapy; HCT, hematocrit; OR, operating room;
SIRS, systemic inﬂammatory response syndrome; WBC, white blood cell count.
aHistory of diabetes mellitus, current smoker status, cardiac, pulmonary, renal and neurologic comorbidities, pre-op platelet count, and deaths were not
statistically signiﬁcant.
bFisher exact test.
Categorical variables are represented as number (%) and continuous variables as mean 6 standard deviation.
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direct resources toward those within the high-risk and
highest-risk cohorts. Whereas the top third of patients
had a predicted readmission rate of 16.4%, this rate doubles
in the top 5% to 35.2%, suggesting that these patients are at
a very high risk for readmission, necessitating targeted
intervention potentially including longer length of stay
and a patient-speciﬁc outpatient plan.
This study is the largest series dedicated to unplanned
readmissions in major vascular surgery, demonstrating
an overall readmission rate of 10.1%. Although readmission
rates vary widely in the literature, depending on time
horizon and speciﬁc procedures evaluated, the reported
parameter is similar to that found in a small single-center
series of Medicare beneﬁciaries in which the readmission
rate was 11.9%.14Readmission within 30 days is associated with a
number of risk factors. The importance of speciﬁc
comorbidities and conditions may vary between disease
processes, but this study found common conditions
among vascular surgery patients associated with increased
readmission risk. Brooke et al,4 in their review of vascular
surgery rehospitalization, laid a conceptual framework for
readmission. They outlined four key phases in the read-
mission process, including phase 1: patient, procedural,
and structural characteristics; phase 2: postoperative
care; phase 3: planning and executing patient discharge;
and phase 4: the readmission itself.4 The current study
deﬁned a number of risk factors in every phase with
the exception of phase 4. Phase 1 risk factors included
race, comorbidities, nonelective cases, and operative
time. Phase 2 factors included VTE and graft failure.
Table III. Binary logistic regression for 30-day
unplanned readmission
Risk factor OR 95% CI P value
Black/African American 1.21 1.04-1.41 .014
Bleeding disorder 1.19 1.05-1.36 .008
Diabetes 1.13 1.00-1.28 .044
Renal comorbidity 1.24 1.02-1.50 .033
Pulmonary comorbidity 1.35 1.17-1.56 <.001
Cardiac comorbidity 1.28 1.13-1.44 <.001
Steroids 1.36 1.07-1.73 .012
Hypoalbuminemia 1.35 1.18-1.55 <.001
Anemia (HCT <36) 1.26 1.10-1.43 .001
Nonelective case 1.15 1.02-1.31 .027
Operative time >150 min 1.17 1.01-1.34 .031
Procedure (reference ¼ carotid) <.001
EVAR 1.06 0.85-1.32 .616
Amputation 1.24 0.99-1.53 .057
Open AAA 1.53 1.18-1.98 .001
Other major procedure 1.49 1.24-1.80 <.001
Peripheral 1.93 1.59-2.34 <.001
VTE before discharge 1.83 1.00-3.36 .050
Graft failure 2.07 1.03-4.134 .040
Disposition (reference ¼ home) <.001
Disposition (rehab/facility) 1.30 1.12-1.50 <.001
Disposition SNF (home) 1.54 1.13-2.10 .007
AAA, Abdominal aortic aneurysm; CI, conﬁdence interval; EVAR, endo-
vascular abdominal aortic repair; HCT, hematocrit; OR, odds ratio; SNF,
skilled nursing facility; VTE, venothromboembolism.
Table IV. Vascular surgery readmission risk score
Risk factor Points Score
Black/African American 1
Pulmonary comorbidity 2
Cardiac comorbidity 2
Renal comorbidity 1
Hypoalbuminemia 2
Anemia (HCT <36) 2
Steroids 2
Bleeding disorder 1
Diabetes 1
Nonelective case 1
Operative time >150 min 1
Procedure (reference ¼ carotid) 0
EVAR 0
Open AAA 3
Peripheral 5
Amputation 1
Other 3
Disposition (reference ¼ home) 0
Disposition nursing facility (home) 3
Disposition (rehab, facility) 2
VTE before discharge 4
Graft failure before discharge 5
Total
AAA, Abdominal aortic aneurysm; EVAR, endovascular abdominal aortic
repair; HCT, hematocrit; VTE, venothromboembolism.
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data were available on phase 4 factors regarding the
readmission itself other than the unplanned nature.
Prior studies have identiﬁed age as a risk factor for
readmission. Age did not improve the model’s predictive
power, and prior studies evaluating age have had mixed re-
sults. Frailty as assessed by dependent status and albumin
may have more impact on 30-day readmissions than does
age.15 Sex has also been suggested as a risk factor for read-
mission, and female sex was associated with readmission
on bivariate analysis in this study but was not an indepen-
dent predictor of readmission on multivariable analysis.
Procedure-speciﬁc studies have found mixed results
regarding the impact of sex on readmissions.5,6,16,17
Another commonly described risk factor is a measure
of overall health, based on either ASA class or Charlson
Comorbidity Index.5,17 The proposed risk score does not
include a global assessment of health, and the inclusion
of individual risk factors including pulmonary, cardiac,
and renal comorbidities had the best performance.
In assessing procedures individually, recent studies
have found both common and independent risk factors.
Similarities and differences between the entire vascular
surgery cohort and speciﬁc procedures will be discussed
below. Overall CE had the lowest readmission rate, at
6.2%. In another study that evaluated only CE readmis-
sions within NSQIP, similar risk factors were identiﬁed
with the addition of neurological comorbidity, although
they did not speciﬁcally address hypoalbuminemia or ane-
mia.17 Their ﬁndings suggest that within NSQIP, the onlyCE-speciﬁc readmission risk factor is prior cerebrovascular
accident. Neurological comorbidity was associated with
readmission within our study but did not improve
prediction of readmission on multivariable analysis. Ram-
bachan et al17 also separated comorbidities and complica-
tions, assuming that complications were the reason for
readmission. Their CE model, based on preoperative
comorbidities, had a lower C-statistic, suggesting worse
model performance.17 Furthermore, Rambachan et al17
failed to separate predischarge and postdischarge compli-
cations, which confuses factors that may increase risk, as
was demonstrated in the case of VTE, with those that
may be the cause for readmission. This error probably
contributed to the modest C-statistic of 0.58 for the
complication model.17 NSQIP currently does not provide
reasons for readmission and thus assumes that post-
discharge complications as the cause of readmission may
be inappropriate.
AAA had a greater risk of readmission at 30 days than
did EVAR in the current study. This ﬁnding has been
corroborated in a prior study of aortic aneurysm repair in
California. In the study by Casey et al,16 open repairs
were more likely to be readmitted to the hospital. This dif-
ference, however, was absent at 4 months after surgery and
in fact reversed at 1 year, in which EVAR was associated
with an increased rate of readmission on the Kaplan-
Meier curve (P ¼.009).16 The readmission rate at 1 year
in the Casey study was exceedingly high, at 55.4% and
52.1%, compared with 7.5% and 9.2% at 30 days in the cur-
rent study for EVAR and AAAs, respectively. This study
also showed that early readmission in the AAA group pre-
sented sooner than did EVAR and were secondary to
Fig 2. Validation dataset observed and predicted readmission rate by risk score.
Fig 1. Predicted probability of unplanned readmission by readmission risk score within the validation dataset.
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complications, infection, VTE, or small-bowel obstruc-
tion.16 These causes of readmission were in stark contrast
to EVAR, in which the readmission diagnosis was mostfrequently device-related, an aneurysm complication, or a
wound complication.16 Upcoming initiatives that will affect
vascular surgery are largely focused on the short-term read-
mission rate, and the ﬁndings of Casey et al suggest that
JOURNAL OF VASCULAR SURGERY
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missions in aortic repair. The current study focused on
short-term readmissions, and initial attempts to reduce
unplanned readmissions probably will favor EVAR over
AAAs in appropriately selected patients, with the caveat
of increased readmission at 1 year.
Lower extremity revascularization is associated with the
greatest risk of readmission, at 15.2% in the current study.
Previously reported ranges vary widely from <10% to
>20% after lower extremity bypass.5 Vogel et al5 evaluated
readmissions among patients undergoing procedures for
peripheral arterial disease within the Health Facts database
and found a 14.5% 30-day readmission rate. The additional
risk factors that they identiﬁed included length of
stay, aspartate aminotransferase, and >30 medications
ordered.5 NSQIP does not include the number of medica-
tions but remains an interesting risk factor because of its
implications about the patient’s overall health state and
the complexity of optimizing multiple medication dosages,
especially after a protracted hospital stay. The Vogel study
was able to identify the cause of readmission, which is not
possible currently in NSQIP. They found that 22.1% of
readmissions were secondary to surgical infection.5
McPhee et al6 also evaluated lower extremity bypasses at
a single academic center and reported a readmission rate
of 23%. McPhee et al6 also found an association between
inpatient surgical site infections and readmission in lower
extremity bypass that was not found in our study. This
may in part be due to the assessment of multiple proce-
dures, in which the incisional infection risk is variable. In
congruence with our ﬁndings, McPhee et al6 also demon-
strated that graft failure before discharge was associated
with readmission. Readmission after lower extremity bypass
was also associated with increased risk of limb loss.6
Another interesting ﬁnding of the McPhee study is that
the unplanned readmission rate did not decrease over
time despite practitioner and institutional awareness, lead-
ing to the suggestion that institutions and individuals
may not be able to inﬂuence unplanned readmissions in
this complex patient population and therefore should not
be penalized.6
Whether or not identiﬁcation of high-risk patients
and implementation of process measures reduces un-
planned readmissions remains to be seen. Evidence across
all medical specialties suggests that adherence to current
process measures for readmission do not reduce readmis-
sion rates in vascular or other major surgeries and have
only a small impact on acute myocardial infarction and
pneumonia readmissions.18 Whereas current process mea-
sures may fail to reduce readmissions, interventions may
play a role, including increased care coordination that in-
cludes communication and follow-up with the primary
care physician. Other measures focused on adherence to
prescribed medicine play a large role in medical readmis-
sions but may have less impact among surgical patients.
As described in the McPhee study, despite increased
awareness, readmission rates did not decrease over time,
which may suggest that the inclusion of the complexbut smaller vascular patient population in an incentive-
based readmission program may not have as large of an
economic impact as other larger-volume, higher-cost
diagnoses.6
This study has inherent limitations, in part secondary to
its retrospective nature, but also related to NSQIP’s lack of
vascular-related variables. Although some clinical parame-
ters that have import on readmissions may be lacking,
NSQIP has been shown to approach thorough chart
reviews and exceeds administrative databases in capturing
unplanned readmissions and their causes.19,20 Another lim-
itation to this study is the modest C-statistic of 0.67.
Although modest, when compared with prior models
aimed at predicting readmission, this model performs rela-
tively well; for instance, a model predicting heart failure
readmissions had a C-statistic ranging from 0.57-0.61,
depending on the administrative database that was evalu-
ated.21 Our model also performed better than did vascular
procedure-speciﬁc models.17 The predictive model incor-
porates preoperative, operative, and in-hospital data to
determine a patient’s likelihood of return to the hospital.
Future study should attempt to determine the relative
importance of preoperative characteristics and the role of
preoperative optimization on reducing readmissions. This
study lacked information regarding the readmission itself,
and future study should be directed at applying this model
prospectively to vascular surgery patients to identify the
reason, timing, and potential preventability for 30-day
unplanned readmissions.
CONCLUSIONS
This study identiﬁes risk factors for readmission after
vascular surgery and provides a simple predictive risk score
that accurately identiﬁes patients at high risk for readmis-
sion. This model stratiﬁes readmission risk on the basis of
procedure type, which suggests that attempts to decrease
vascular readmission should focus on peripheral revascular-
ization procedures.
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1347.e1 Iannuzzi et al May 2014APPENDIX (online only). Procedure grouping by
Current Procedural Terminology (CPT ) codesProcedure group CPT codes
Open AAA
34820, 34830, 34832, 35081, 35091, 35102, 35141, 35540
Endovascular aortic repair
34800, 34802, 34803, 34805, 34812, 34834
Peripheral extremity intervention
34813, 35011, 35151, 35351, 35355, 35556, 35558, 35566,
35583, 35585, 35587, 35666, 35671
CE
35301, 35390, 27590, 27592, 27880, 27882
Lower extremity amputation
27880, 27882, 27590, 27592
Other
34804, 34808, 34825, 34831, 34833, 34900, 35001, 35005,
35111, 35121, 35131, 35331, 35341, 35361, 35363, 35501,
35506, 35508, 35509, 35510, 35526, 35531, 35533, 35535,
35537, 35538, 35539, 35548, 35549, 35551, 35560, 35563,
35601, 35606, 35621, 35623, 35626, 35631, 35633, 35634,
35636, 35637, 35638, 35642, 35646, 35647, 35650, 35651,
35654, 35656, 35661, 35663, 35665, 35691, 35694, 35695,
35697
AAA, Abdominal aortic aneurysm; CE, carotid endarterectomy.
